PharmaNet hires vp for clinical operations

Catherine Derasp will oversee Phase I clinics

Catherine Derasp has joined PharmaNet Development Group, a US provider of clinical development services to the pharmaceutical and biotechnology industry, as vice president, clinical operations of the company's Phase I clinics.

Derasp will oversee the management of the company's 350-bed Phase I clinical operations that are located in Montreal and Quebec City, Canada. In addition to first-in-man and proof-of-concept phase I clinical services, she will be responsible for a variety of studies in special populations, cardiac safety testing, and drug-drug interaction studies.

You may also like

Regulatory

Standard proposed to clarify endotoxin testing for single-use systems

The guide will address variability when assessing bacterial endotoxins on large-scale pharmaceutical equipment
Regulatory

AlzeCure's pain project ACD440 granted orphan drug status in the US by the FDA

AlzeCure Pharma announces that the US Food and Drug Administration (FDA) has granted the company's application for orphan drug status for the clinical pain candidate drug ACD440
Manufacturing

Precision under pressure

Why pharma manufacturing needs a harder look at weight control
Manufacturing

Gerresheimer achieves leadership status with A- CDP score

Sustainability progress earns strong rating for climate disclosure and emissions strategy
Regulatory

Why rigorous clinical evaluations matter: strategies to boost safety and compliance

This white paper provides a blueprint for achieving excellence in clinical evaluations through strategic enhancements
Manufacturing

WLS introduces PR-12 and PR-24 plunger rod insertion and labelling systems

By improving reliability and streamlining production, the PR-12 and PR-24 help pharmaceutical manufacturers and contract packers protect product quality and reduce waste while maximising operational efficiencies
Packaging

Are your industry inks as compliant as you think? Be audit-ready, every time

As global regulations around product packaging tighten and compliance audits become more frequent, Domino Printing Sciences (Domino) is highlighting the critical importance of ink safety
Subscribe now